-
Update your practice: The Centers for Disease Control and Prevention (CDC) no longer recommends the oral antibiotic cefixime as a first-line treatment option for gonorrhea due to possible drug resistance.
-
The authors performed a nested case-control study using data from the Rochester Epidemiology Project which conducts population-based studies of the residents of Olmsted County, Minnesota.
-
In this issue: Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
-
Data were accessed from the nurses health study, which enrolled 121,700 U.S. female registered nurses who were 30-55 years old at the outset in 1976. Every 2 years, participants provided information about their lifestyle, medical history, and illnesses via mailed questionnaires.
-
To evaluate the effectiveness of mammography as a screening test, the authors used the Surveillance, Epidemiology, and End Results (SEER) database to examine trends from 1976 through 2008 in the incidence of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older in the United States.
-
-
There has been a steady rise of labor inductions in the United States during the last decade, a trend that has gone hand-in-hand with the cesarean section rate.
-
The association between high surgical volume and improved procedure-based outcome is ubiquitous, yet without clarity as to why the association is so prevalent. One hypothesized mechanism is that high-volume hospitals may be better at rescuing patients with complications, rather than having lower complication rates.
-
-
The different drug formulations of menopausal hormone therapy (HT) may determine the risk of venous thromboembolism (VTE), according to a new study.
